Filter
476
Featured
57
20
Language
Document type
130
128
54
48
32
28
18
8
6
5
5
3
2
1
Countries / Regions
26
26
13
12
9
8
6
5
5
4
4
4
4
3
3
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
71
34
12
8
6
6
6
6
5
5
4
4
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Toolboxes
26
23
22
22
19
19
17
17
17
17
16
16
16
16
15
15
13
13
13
13
12
12
12
11
11
11
11
11
11
11
11
10
10
10
9
9
9
9
9
9
8
8
8
8
8
7
7
7
7
7
6
6
6
6
6
5
5
5
4
4
4
4
4
4
4
4
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Braz. Oral Res. 2025;39:e0
Background Note: Briefing to the Executive Board, First Regular Session 2025
This ToR outlines the background, purpose,
audience, and use of the evaluation, objective and key evaluation questions,
methodological considerations, timeline and deliverables, and the technical
requirements the prospective evaluation team should meet
Preprint VeriXiv 2025, 2:226 Last updated: 20 OCT 2025
Progress on the sustainable development goals.
Policy information sheet
Information Sheet
the WHO AIDS Medicines and Diagnostics Service (AMDS) created a platform to improve access through the internet to procurement and supply management (PSM) tools. WHO/AMDS in collaboration with the AMDS partner network developed it further. It has evolved into a database that lists available PSM tool
...
IAPAC provides guidance to clinicians and allied health professionals through normative guidance that encapsulates evidence-based approaches to optimizing the prevention, care, treatment, and support services delivered to people living with HIV
This module provides considerations for managing and preventing common comorbidities, co-infections and opportunistic infections among PWH.
With the advent and ongoing development of novel antiretroviral agents, people living with HIV (PLWHIV) are living longer and experiencing the effects of HIV infection on aging. The success of antiretroviral therapy (ART) has transformed HIV from a fatal disease into a manageable chronic condition,
...
The standards of care for HIV define the expected or desired quality of prevention, treatment, and care for people at risk of HIV acquisition or living with HIV.
The standards are based on a scientific rationale, as well as the responsibilities of each stakeholder, to ensure that people receive app
...
The information in the brief version is excerpted directly from the full-text guidelines. The brief version is a compilation of the tables and boxed recommendations. The guidelines were updated to comply with Executive Orders
Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents With HIV
recommended
The Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and
Adolescents With HIV document is published in an electronic format and updated as relevant changes
in prevention and treatment recommendations occur.
Guidelines for the Prevention and Treatment of Opportunistic Infections in Children With and Exposed to HIV
recommended
Full Guidelines
Dosing Recommendations for Prevention and Treatment
Archives of Medicine vo.7 no.5:10
Individuals infected with human immunodeficiency virus (HIV) often develop
multiple complications and comorbidities, among them, opportunistic infections.
The highest incidence of opportunistic infections was reported in the group
of patients with CD4 lymphocyte
...
PLoS One 20(5): e0319807. https://doi.org/10.1371/journal.pone.031980
The implementation of people-centered, evidence-driven, culturally, and religiously
sensitive program enabled SFH to reach a high number of AP in northern Nigeria. This
helps improve equity in access to care by AP. There are sp
...
J Urban Health (2025) 102:1208–1222 https://doi.org/10.1007/s11524-025-01021-7
The Department of Global HIV, Hepatitis and Sexually Transmitted Infections Programmes leads the development and implementation of the global health sector strategies on HIV, viral hepatitis, and sexually transmitted infections for ending AIDS and the epidemics of viral hepatitis and STIs by 2030
